1. Home
  2. GIB vs FMS Comparison

GIB vs FMS Comparison

Compare GIB & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CGI Inc.

GIB

CGI Inc.

HOLD

Current Price

$64.47

Market Cap

12.8B

ML Signal

HOLD

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$23.25

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIB
FMS
Founded
1976
1996
Country
Canada
Germany
Employees
N/A
108165
Industry
Professional Services
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
12.5B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
GIB
FMS
Price
$64.47
$23.25
Analyst Decision
Hold
Sell
Analyst Count
3
2
Target Price
$112.00
$30.00
AVG Volume (30 Days)
456.6K
627.3K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.70%
2.57%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.33
N/A
Revenue Next Year
$2.96
$3.83
P/E Ratio
$13.59
$15.62
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$20.02
52 Week High
$106.68
$28.87

Technical Indicators

Market Signals
Indicator
GIB
FMS
Relative Strength Index (RSI) 44.63 55.93
Support Level $60.78 $22.50
Resistance Level $70.68 $23.36
Average True Range (ATR) 1.93 0.31
MACD -0.27 0.07
Stochastic Oscillator 53.16 64.25

Price Performance

Historical Comparison
GIB
FMS

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: